SVR rates are higher among HCV G1 patients with elevated low-density lipoprotein (LDL) levels when treated with intensified doses of peginterferon alfa-2a (pegasys®) plus ribavirin

Category Primary study
JournalJournal of Hepatology
Year 2011
This article has no abstract
Epistemonikos ID: 8271dc0c4565c5b8e6418136f95e0e073cc08b85
First added on: Feb 04, 2025